Comparison of dose calculation methods for brachytherapy of intraocular tumors. - Wikidata - awgldk - TriplyDB

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

http://www.wikidata.org/entity/Q34493736

about

Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167.Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.Keeping an eye on the ring: COMS plaque loading optimization for improved dose conformity and homogeneity.(103)Pd versus (125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.BEDVH-A method for evaluating biologically effective dose volume histograms: application to eye plaque brachytherapy implants.Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).Feasibility and clinical value of CT-guided (125)I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.Comparison of 16 mm OSU-Nag and COMS eye plaques.A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using I COMS plaques

P2860

Q30151984-E1DE949A-9804-4B14-89FC-D0F5F8B227C9 Q38049632-AC9859D6-D012-4442-8E8A-448A9950DC27 Q38186120-5B7C0D5F-3DBE-44E7-8C18-ABD55336C1F8 Q38193210-969E7E00-5A08-4410-8B4F-627A9A02CDC5 Q41824320-4396CDF2-BB2F-4F29-AB1E-9343F0FC56EB Q42037875-53E93822-045A-462A-8E1D-10BDD3B20D76 Q42465010-F1D47AE6-85B5-44BF-8DE1-2792F14C0530 Q46673817-064191D8-31B3-4A5F-A602-0657AFBEFD2F Q47424554-EAF7E134-9096-41D7-A198-8CCD074E3D55 Q49021743-91259685-23B3-41F0-8FED-E49D8116B6B2 Q49691413-E9F901C0-AF13-469B-A114-015A8F37F1DE Q55629477-4C53A59B-DF06-4904-BCC6-641EE384EDC9 Q59127189-0D5AB95D-3C3A-431E-92FF-B144E14FF465

P2860

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

http://www.wikidata.org/entity/Q34493736

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@ast

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@en

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@nl

type

label

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@ast

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@en

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@nl

prefLabel

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@ast

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@en

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

@nl

P1433

Q34493736-A87CD0A5-CF13-46F5-B8F7-10A06691994E

P1476

Q34493736-45AC097A-7CC4-4291-83B0-08FA0917EA39

P2093

Q34493736-44458DE7-84C3-4DE9-AF01-392CC5BA746A

Q34493736-52F6CA26-8BBE-4FF6-A039-474347E053D0

Q34493736-68A10D38-2F10-47D5-8B3D-0131D6A5F404

Q34493736-76F8CF22-AB85-490E-9B7B-2B614596D96F

Q34493736-8691CC90-CB7C-4425-9E51-20927FF01A53

Q34493736-B8F222D7-7158-43F9-8855-A619EAE61DCC

Q34493736-D5FD73BC-D594-4B96-AB13-D987F1AA3C36

Q34493736-F959B844-6F7D-45FF-8293-55631D13BB6A

P2860

Q34493736-01827C74-E718-456D-94B6-A29C7877EF03

Q34493736-040837DC-746D-46B1-978F-30CA6ED3F31A

Q34493736-0F85A9A2-3530-4533-B30D-1E5D71FBE2C9

Q34493736-13ADEB8F-3800-4BFC-830F-3FA8807505E1

Q34493736-268DECBA-32F9-42CF-9B0A-87C075B6BB8E

Q34493736-2F51EBDF-F953-4EA7-8DEA-342322C83230

Q34493736-3F5B1EA2-390D-43B4-94C9-6D45405DAA61

Q34493736-4DEFBE17-B10F-4018-817F-D69F2CC169D9

Q34493736-60E58836-004A-494D-83CD-EE77C2846A5D

Q34493736-64FC80D7-0902-4AD2-8E8A-25267F55FC13

P304

Q34493736-D71ABC67-8F6E-44BD-B06C-B07734004CD9

P31

Q34493736-0490E0AB-4DDE-4A45-A233-29FC11BD409A

P356

Q34493736-6D97F423-8AE3-4FEA-9742-0E94695E5247

P407

Q34493736-A3610FF4-8497-4292-9D69-B074E0496DE9

P433

Q34493736-E980B716-BC4C-48D5-979C-BFA7B29637FA

P478

Q34493736-73940A73-E325-478E-90FB-FF35D1BC1126

P50

Q34493736-1B67F21B-F94C-4CE7-A306-F2EEE62F35D6

Q34493736-F27E4F46-7D02-44B8-BEE3-A4CBE0FB7163

P577

Q34493736-383DB7A2-FF54-4500-8606-9F4F2D825BD9

P5875

Q34493736-AFCD24E9-DBD3-430A-8FD9-4CD14A944C89

P698

Q34493736-30426861-5528-48B6-8166-2726108408F3

P921

Q34493736-83D0DC2A-800B-4F24-B0CC-505F08D1180B

P932

Q34493736-729E9776-27C4-4231-8A5D-CF3936525CC0

P356

P1433

Medical Physics

P1476

Comparison of dose calculation methods for brachytherapy of intraocular tumors

@en

P2093

Ali S Meigooni

http://www.w3.org/2001/XMLSchema#string

D W O Rogers

http://www.w3.org/2001/XMLSchema#string

Firas Mourtada

http://www.w3.org/2001/XMLSchema#string

Mark J Rivard

http://www.w3.org/2001/XMLSchema#string

Mary E Napolitano

http://www.w3.org/2001/XMLSchema#string

Ravinder Nath

http://www.w3.org/2001/XMLSchema#string

Rowan M Thomson

http://www.w3.org/2001/XMLSchema#string

Sou-Tung Chiu-Tsao

http://www.w3.org/2001/XMLSchema#string

P2860

The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.

The evolution of brachytherapy treatment planning.

Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms.

An EGSnrc Monte Carlo-calculated database of TG-43 parameters.

Improved treatment planning for COMS eye plaques.

Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.

Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy.

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.

Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma.

P304

306-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1118/1.3523614

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Christopher S. Melhus

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50248210

http://www.w3.org/2001/XMLSchema#string

P698

21361199

http://www.w3.org/2001/XMLSchema#string

P921

P932

3021559

http://www.w3.org/2001/XMLSchema#string